Low molecular mass permeation enhancers in oral delivery of macromolecular drugs

Oral Delivery of Macromolecular Drugs

Volumn , Issue , 2009, Pages 85-101

  Bernkop Schnürch, Andreas ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84900766222     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-0200-9_5     Document Type: Chapter

References (72)

1. Anderberg EK, Lindmark T, Artursson P (1993) Sodium caprate elicits dilatations in human intestinal tight junctions and enhances drug absorption by the paracellular route. Pharm Res 10:857-864
2. 2EDTA, and aprotinin on rectal, nasal, and buccal insulin delivery. Pharm Res 5:305-308
3. Aungst BJ, Saitoh H, Burcham DL, Huang S-M, Mousa SA, Hussain MA (1996) Enhancement of the intestinal absorption of peptides and non-peptides. J Contr Rel 41:19-31
4. Baluom M, Friedman M, Rubinstein A (1998) The importance of intestinal residence time of absorption enhancer on drug absorption and implication on formulative considerations. Int J Pharm 176:21-30
5. Baudry B, Fasano A, Ketley J, Kaper JB (1992) Cloning of a gene (zot) encoding a new toxin produced by Vibrio cholerae. Infect Immun 60:428-434
6. Bernkop-Schnürch A, Krajicek ME (1998) Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan-EDTA conjugates J Control Rel 50:215-23
7. Bowe CL, Mokhtarzadeh L, Venkatesan P, Babu S, Axelrod HR, Sofia MJ, Kakarla R, Chan TY, Kim JS, Lee HJ, et al. (1997) Design of compounds that increase the absorption of polar molecules. Proc Natl Acad Sci USA 94:12218-12223
8. Brayden D, Creed E, O'Connell A, Leipold H, Argawal R, Leone-Bay A (1997) Heparin absorption across the intestine: effects of sodium N-[8-(2- hydroxybenzoyl) amino]caprylate in rat in situ intestinal instillations and in Caco-2 monolayers. Pharm Res 14:1772-1779
9. Burcham DL, Aungst BJ, Hussain M, Gorko MA, Quon CY, Huang S-M (1995) The effect of absorption enhancers on the oral absorption of the GPIIb/IIIa receptor antagonist, DMP 728, in rats and dogs. Pharm Res 12:2065-2070
10. Chao AC, Nguyen JV, Broughall M, Recchia J, Kensil CR, Daddona PE, Fix JA (1998a) Enhancement of intestinal model compound transport by DS-1, a modified Quillaia saponin. J Pharm Sci 87:1395-1399
11. Chao AC, Taylor MT, Daddona PE, Broughall M, Fix JA (1998b) Molecular weightdependent paracellular transport of fluorescent model compounds induced by palmitoylcarnitine chloride across the human intestinal epithelial cell line Caco-2. J Drug Targeting 6:37-43
12. Chao AC, Nguyen JV, Broughall M, Griffin A, Fix JA, Daddona PE (1999) In vitro and in vivo evaluation of effects of sodium caprate on enteral peptide absorption and on mucosal morphology. Int J Pharm 191:15-24
13. Chelminska-Bertilsson M, Edebo A, Thompson RA, Edebo L (1995) Enzymatic hydrolysis of long-chain alkanoylcholines in rat intestinal loops. Scand J Gastroenterol 30:670-674
14. Constantinides PP, Scalart J-P, Lancaster C, Marcello J, Marks G, Ellens H, Smith PL (1994) Formulation and intestinal absorption enhancement evaluation of water-in-oil microemulsions incorporating medium-chain glycerides. Pharm Res 11:1385-1390
15. Cox D, Raje S, Gao H, et al. (2002) Enhanced permeability of molecular weight markers and poorly bioavailable compounds across Caco-2 cell monolayers using the absorption enhancer, Zonula Occludens toxin. Pharm Res 19:1680-1688
16. Di Pierro M, Lu R, Uzzau S, et al. (2001) Zonula Occludens toxin structure-function analysis: identification of the fragment biologically active on tight junctions and of the Zonulin receptor binding domain J Biol Chem 276:19160-19165
17. Duizer E, Van der Wulp C, Versantvoort CHM, Groten JP (1998) Absorption enhancement, structural changes in tight junctions and cytotoxicity caused by palmitoyl carnitine in Caco-2 and IEC-18 cells. J Pharmacol Exp Ther 287:395-402
18. Fasano A (2001) Intestinal Zonulin: open sesame! Gut 49:159-162
19. Fasano A, Uzzau S (1997) Modulation of intestinal tight junctions by Zonula Occludens toxin permits enteral administration of insulin and other macromolecules in an animal model. J Clin Invest 99:1158-1164
20. Fasano A, Baudry B, Pumplin D, et al. (1991) Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions. Proc Natl Acad Sci USA 88:5242-5246
21. Fasano A, Uzzau S, Fiore C, MararettenK (1997) The enterotoxic effect of Zonula Occludens toxin on rabbit small intestine involves the paracellular pathway. Gastroentrology 112:839-846
22. Fix JA (1996) Strategies for delivery of peptides utilizing absorption-enhancing agents. J Pharm Sci 85:1282-1285
23. Fix JA, Engle K, Porter PA, Leppert PS, Selk SJ, Gardner CR, Alexander J (1986) Acylcarnitines: drug absorption-enhancing agents in the gastrointestinal tract. Am J Physiol 251:G332-G340
24. Hastewell J, Lynch S, Fox R, Williamson I, Skelton-Stroud P, Mackay M (1994) Enhancement of human calcitonin absorption across the rat colon in vivo. Int J Pharm 101:115-120
25. Hellriegel ET, Bjornsson TD, Hauck WW (1996) Interpatient variability in bioavailability is related to the extent of absorption: implications for bioavailability and bioequivalence studies. Clin Pharmacol Ther 60:601-607
26. Hochman JH, Fix JA, LeCluyse EL (1994) In vitro and in vivo analysis of the mechanism of absorption enhancement by palmitoylcarnitine. J Pharmacol Exp Ther 269:813-822
27. Hoffman A, Qadri B (2008) Eligen insulin-a system for the oral delivery of insulin for diabetes. IDrugs 11:433-41
28. Imai T, Sakai M, Ohtake H, Azuma H, Otagiri M (1999) In vitro and in vivo evaluation of the enhancing activity of glycyrrhizin on the intestinal absorption of drugs. Pharm Res 16:80-86
29. Knipp GT, Ho NFH, Barsuhn CL, Borchardt RT (1997) Paracellular diffusion in Caco-2 cell monolayers: effect of perturbation on the transport of hydrophilic compounds that vary in charge and size. J Pharm Sci 86:1105-1110
30. LeCluyse EL, Sutton SC, Fix JA (1993) In vitro effects of long-chain acylcarnitines on the permeability, transepithelial electrical resistance and morphology of rat colonic mucosa. J Pharmacol Exp Ther 265:955-962
31. Leone-Bay A, Paton DR, Freeman J, Lercara C, O'Toole D, Gschneidner D, Wang E, Harris E, Rosado C, Rivera T, et al. (1998a) Synthesis and evaluation of compounds that facilitate the gastrointestinal absorption of heparin. J Med Chem 41:1163-1171
32. Leone-Bay A, Paton D, Variano B, Leipold H, Rivera T, Miura-Fraboni J, Baughman RA, Santiago N (1998b) Acylated non-a-amino acids as novel agents for the oral delivery of heparin sodium, USP. J Contr Rel 50:41-49
33. Lin X, Xu DS, Feng Y, Li SM, Lu ZL, Shen L (2006) Release-controlling absorption enhancement of enterally administered Ophiopogon japonicus polysaccharide by sodium caprate in rats. J Pharm Sci 95:2534-42
34. Lindmark T, Nikkilä T, Artursson P (1995) Mechanisms of absorption enhancement by medium chain fatty acids in intestinal epithelial Caco-2 cell monolayers. J Pharmacol Exp Ther 275:958-964
35. Lindmark T, Kimura Y, Artursson P (1998) Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells. J Pharmacol Exp Ther 284:362-369
36. Lindmark T, Schipper N, Lazorová L, de Boer AG, Artursson P (1997) Absorption enhancement in intestinal epithelial Caco-2 monolayers by sodium caprate: assessment of molecular weight dependence and demonstration of transport routes. J Drug Targeting 5:215-223
37. Lohikangas L, Wilen M, Einarsson M, Artursson P (1994) Effects of a new lipid-based drug delivery system on the absorption of low molecular weight heparin (Fragmin) through monolayers of human intestinal epithelial Caco-2 cells and after rectal administration to rabbits. Eur J Pharm Sci 1:297-305
38. Lundin PDP, Bojrup M, Ljusberg-Wahren H, Weström BR, Lundin S (1997) Enhancing effects of monohexanoin and two other medium-chain glyceride vehicles on intestinal absorption of desmopressin (dDAVP). J Pharmacol Exp Ther 282:585-590
39. Milstein SJ, Leipold H, Sarubbi D, Leone-Bay A, Mlynek GM, Robinson JR, Kasimova M, Freire E (1998) Partially unfolded proteins efficiently penetrate cell membranes - implications for oral drug delivery. J Contr Rel 53:259-267
40. Morishita M, Matsuzawa A, Takayama K, Isowa K, Nagai T (1998) Improving insulin enteral absorption using water-in-oil-in-water emulsion. Int J Pharm 172:189-198
41. Nishihata T, Rytting JH, Kamada A, Higuchi T, Routh M, Caldwell L (1983) Enhancement of rectal absorption of insulin using salicylates in dogs. J Pharm Pharmacol 35:148-151
42. Noach ABJ, Kurosaki Y, Blom-Roosemalen MCM, de Boer AG, Breimer DD (1993) Cellpolarity dependent effect of chelation on the paracellular permeability of confluent Caco-2 cell monolayers. Int J Pharm 90:229-237
43. Rivera TM, Leone-Bay A, Paton DR, Leipold H, Baughman RA (1997) Oral delivery of heparin in combination with sodium N-[8-(2-hydroxybenzoyl) amino]caprylate: pharmacological considerations. Pharm Res 14:1830-1834
44. Sakai K, Kutsuna TM, Nishino T, Fujihara Y, Yata N (1986) Contribution of calcium ion sequestration by polyoxyethylated nonionic surfactants to the enhanced colonic absorption of p-aminobenzoic acid. J Pharm Sci 75:387-390
45. Sakai M, Imai T, Ohtake H, Azuma H, Otagiri M (1997) Effects of absorption enhancers on the transport of model compounds in Caco-2 cell monolayers: assessment by confocal laser scanning microscopy. J Pharm Sci 86:779-785
46. Sakai M, Imai T, Ohtake H, Otagiri M (1998) Cytotoxicity of absorption enhancers in Caco-2 cell monolayers. J Pharm Pharmacol 50:1101-1108
47. Salama NN, Fasano A, Lu R, et al. (2003) Effect of the biologically active fragment of Zonula Occludens toxin, ΔG, on the intestinal paracellular transport and oral absorption of mannitol. Int J. Pharm 251:113-121
48. Salama NN, Fasano A, Thakar M, et al. (2004) The effect of ΔG on the transport and oral absorption of macromolecules. J Pharm Sci 93:1310-1319
49. Salama NN, Fasano A, Thakar M, et al. (2005) The effect of ΔG on the oral bioavailability of low bioavailable therapeutic agents. J Pharmacol Exp Ther 312:199-205
50. Salzman AL, Menconi MJ, Unno N, Ezzell RM, Casey DM, Gonzalez PK, Fink MP (1995) Nitric oxide dilates tight junctions and depletes ATP in cultured Caco-2BBe intestinal epithelial monolayers. Am J Physiol 268:G361-G373
51. Sekine M, Maeda E, Sasahara K, Okada R, Kimura K, Fukami M, Awazu S (1985) Improvement of bioavailability of poorly absorbed drugs. III. Oral acute toxicity and local irritation of medium chain glyceride. J Pharmacobio-Dyn 8:633-644
52. Shimazaki T, Tomita M, Sadahiro S, Hayashi M, Awazu S (1998) Absorption-enhancing effects of sodium caprate and palmitoyl carnitine in rat and human colons. Dig Dis Sci 43:641-645
53. Swenson ES, Milisen WB, Curatolo W (1994) Intestinal permeability enhancement: structureactivity and structure-toxicity relationships for nonylphenoxypolyoxyethylene surfactant permeability enhancers. Pharm Res 11:1501-1504
54. Tomita M, Hayashi M, Horie T, Ishizawa T, Awazu S (1988) Enhancement of colonic drug absorption by the transcellular permeation route. Pharm Res 5:786-789
55. Tomita M, Sawada T, Ogawa T, Ouchi H, Hayashi M, Awazu S (1992) Differences in the enhancing effects of sodium caprate on colonic and jejunal drug absorption. Pharm Res 9:648-653
56. Tomita M, Hayashi M, Awazu S (1995) Absorption-enhancing mechanism of sodium caprate and decanoylcarnitine in Caco-2 cells. J Pharmacol Exp Ther 272:739-743
57. Uchiyama T, Yamamoto A, Hatano H, Fujita T, Muranishi S (1996) Effectiveness toxicity screening of various absorption enhancers in the large intestine: intestinal absorption of phenol red and protein and phospholipid release from the intestinal membrane. Biol Pharm Bull 19:1618-1621
58. Utoguchi N, Watanabe Y, Shida T, Matsumoto M (1998) Nitric oxide donors enhance rectal absorption of macromolecules in rabbits. Pharm Res 15:870-876
59. Uzzau S, Fasano A (2000) Cross-talk between enteric pathogens and the intestine. Cell Microbiol 2:83-89
60. Uzzau S, Fiore C, Margaretten K, et al. (1996) Modulation of intestinal tight junctions: a novel mechanism of intestinal secretion. Gastroentrology 110:370
61. Uzzau S, Cappuccinelli P, Fasano A (1999) Expression of Vibrio cholerae Zonula Occludens toxin and analysis of its subcellular localization. Microb Pathog 27:377-385
62. Wang W, Uzzau S, Goldblum S, Fasano A (2000) Human Zonulin, a potential modulator of intestinal tight junctions. J Cell Sci 113:4435-4440
63. Watts TL, Alexander T, Hansen B, et al. (2000) Utilizing the paracellular pathway: a novel approach for the delivery of oral insulin in diabetic rhesus macaques. J Invest Med 48:185
64. Werner U, Kissel T, Reers M (1996) Effects of permeation enhancers on the transport of a peptidomimetic thrombin inhibitor (CRC 220) in a human intestinal cell line (Caco-2). Pharm Res 13:1219-1227
65. Whitehead K, Mitragotri S (2008) Mechanistic analysis of chemical permeation enhancers for oral drug delivery. Pharm Res 25:1412-1419
66. Whitehead K, Karr N, Mitragotri S (2008) Discovery of synergistic permeation enhancers for oral drug delivery. J Control Rel 128:128-33
67. Wu S-Y, Robinson JR (1999) Transcellular lipophilic complex-enhanced intestinal absorption of human growth hormone. Pharm Res 16:1266-1272
68. Yamashita S, Saitoh H, Nakanishi K, Masada M, Nadai T, Kimura T (1987) Effects of diclofenac sodium and disodium ethylenediaminetetraacetate on electrical parameters of the mucosal membrane and their relation to the permeability enhancing effects in the rat jejunum. J Pharm Pharmacol 39:621-626
69. Yamamoto A, Taniguchi T, Rikyuu K, Tsuji T, Fujita T, Murakami M, Muranishi S (1994) Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats. Pharm Res 11:1496-1500
70. Yamamoto A, Uchiyama T, Nishikawa R, Fujita T, Muranishi S (1996) Effectiveness and toxicity screening of various absorption enhancers in the rat small intestine: effects of absorption enhancers on the intestinal absorption of phenol red and the release of protein and phospholipids from the intestinal membrane. J Pharm Pharmacol 48:1285-1289
71. Yamamoto A, Okagawa T, Kotani A, Uchiyama T, Shimura T, Tabata S, Kondo S, Muranishi S (1997) Effects of different absorption enhancers on the permeation of ebiratide, an ACTH analogue, across intestinal membranes. J Pharm Pharmacol 49:1057-1061
72. Yamamoto A, Tatsumi H, Maruyama M, Uchiyama T, Okada N, Fujita T (2001) Modulation of intestinal permeability by nitric oxide donors: implications in intestinal delivery of poorly absorbable drugs. J Pharmacol Exp Ther 296:84-90